| Product Code: ETC7539467 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell And Gene Therapy Clinical Trial Services Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 India Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.8 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 India Cell And Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India |
4.2.2 Growing investments in research and development of cell and gene therapy technologies |
4.2.3 Rising demand for personalized medicine and targeted therapies in the Indian healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for cell and gene therapy clinical trials in India |
4.3.2 Limited infrastructure and expertise in conducting advanced clinical trials for cell and gene therapies in the country |
5 India Cell And Gene Therapy Clinical Trial Services Market Trends |
6 India Cell And Gene Therapy Clinical Trial Services Market, By Types |
6.1 India Cell And Gene Therapy Clinical Trial Services Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F |
6.1.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F |
6.1.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F |
6.1.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F |
6.1.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F |
6.1.8 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Cell And Gene Therapy Clinical Trial Services Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 India Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas |
6.3.1 Overview and Analysis |
6.3.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.4.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F |
6.4.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.4.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
7 India Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 India Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 India Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 India Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Patient recruitment and retention rates for cell and gene therapy clinical trials |
8.2 Time-to-market for new cell and gene therapy products in India |
8.3 Number of partnerships and collaborations between Indian research institutions and global biopharmaceutical companies in the field of cell and gene therapy |
9 India Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.4 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 India Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 India Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 India Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here